Literature DB >> 6319152

The effect of captopril and propranolol on the responses to posture and isometric exercise in patients with essential hypertension.

M J Vandenburg, J M Holly, F J Goodwin, V L Sharman, F P Marsh.   

Abstract

The effects of captopril and propranolol on blood pressure, heart rate and plasma noradrenaline, renin and aldosterone, and on the responses to changes in posture and to isometric exercise were measured in patients with essential hypertension. During placebo administration blood pressure, heart rate and plasma noradrenaline rose on standing and during isometric exercise. The rise in diastolic blood pressure during isometric exercise correlated significantly with the rise in plasma noradrenaline. During captopril treatment blood pressure was significantly lower than during placebo administration when the patients were lying, standing or sitting, but the reduction during isometric exercise was not significant. Plasma renin increased, but heart rate, plasma noradrenaline and plasma aldosterone remained unchanged. The acute changes in blood pressure, heart rate and plasma noradrenaline produced by standing and isometric exercise during captopril treatment were similar to those during placebo administration. During propranolol treatment diastolic blood pressure was significantly lower than during placebo administration when the patients were lying, standing or sitting and during isometric exercise. Heart rate also fell. Plasma noradrenaline during standing, sitting and isometric exercise was significantly greater than during placebo administration. The changes in plasma noradrenaline measured during propranolol treatment with the patients supine were negatively correlated with noradrenaline values obtained during placebo administration: plasma noradrenaline fell in patients with higher, and increased in those with lower, initial concentrations.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6319152     DOI: 10.1007/bf00542509

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  48 in total

1.  Reduction in sympathetic nervous activity as a mechanism for hypotensive effect of propranolol.

Authors:  P J Lewis; G Haeusler
Journal:  Nature       Date:  1975-07-31       Impact factor: 49.962

2.  Decrease in plasma noradrenaline levels following long-term treatment with prindolol in patients with essential hypertension.

Authors:  H M Brecht; F Banthien; W Schoeppe
Journal:  Klin Wochenschr       Date:  1976-11-15

Review 3.  Effects of angiotensin on the central nervous system.

Authors:  W B Severs; A E Daniels-Severs
Journal:  Pharmacol Rev       Date:  1973-09       Impact factor: 25.468

4.  Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension.

Authors:  A C Guyton; T G Coleman; A V Cowley; K W Scheel; R D Manning; R A Norman
Journal:  Am J Med       Date:  1972-05       Impact factor: 4.965

5.  Inhibition of noradrenaline uptake by angiotensin.

Authors:  D Palaic; P A Khairallah
Journal:  J Pharm Pharmacol       Date:  1967-06       Impact factor: 3.765

6.  Dissociation between duration of plasma catecholamine and blood pressure responses to beta-adrenergic blockade in normotensive subjects during physical exercise.

Authors:  G Planz; R Planz
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

7.  Catecholamines and exercise.

Authors:  N J Christensen; H Galbo; J F Hansen; B Hesse; E A Richter; J Trap-Jensen
Journal:  Diabetes       Date:  1979-01       Impact factor: 9.461

8.  Cardiovascular response to isometric exercise in normal adolescents.

Authors:  W P Laird; D E Fixler; F D Huffines
Journal:  Circulation       Date:  1979-04       Impact factor: 29.690

9.  Effect of saralasin upon plasma catecholamines in hypertensive patients.

Authors:  N D Vlachakis; A B Ribeiro; L R Krakoff
Journal:  Am Heart J       Date:  1978-01       Impact factor: 4.749

10.  Epinephrine and norepinephrine are cleared through beta-adrenergic, but not alpha-adrenergic, mechanisms in man.

Authors:  P E Cryer; R A Rizza; M W Haymond; J E Gerich
Journal:  Metabolism       Date:  1980-11       Impact factor: 8.694

View more
  5 in total

Review 1.  Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  R N Brogden; P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

2.  Responses to mental stress and physical provocations before and during long term treatment of hypertensive patients with beta-adrenoceptor blockers or hydrochlorothiazide.

Authors:  K Eliasson; T Kahan; B Hylander; P Hjemdahl
Journal:  Br J Clin Pharmacol       Date:  1987-07       Impact factor: 4.335

3.  Effect of sustained-release verapamil therapy on the blood pressure at rest and on the pressor response to isometric exertion in hypertensive patients.

Authors:  C Cardillo; V Musumeci; L Savi; R Guardigli; N Mores; G Folli
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 4.  Management of hypertension in actively exercising patients. Implications for drug selection.

Authors:  D Klaus
Journal:  Drugs       Date:  1989-02       Impact factor: 9.546

5.  Haemodynamic and hormonal effects of cilazapril in comparison with propranolol in healthy subjects and in hypertensive patients.

Authors:  C H Kleinbloesem; K Erb; J Essig; K Breithaupt; G G Belz
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.